Molecular Templates Inc MTEM

Morningstar Rating
$1.46 +0.05 (3.55%)
View Full Chart

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

MTEM is trading within a range we consider fairly valued.
Price
$1.47
Fair Value
$5.73
Uncertainty
Extreme
1-Star Price
$6.28
5-Star Price
$5.24
Economic Moat
Sbw
Capital Allocation

News

Trading Information

Previous Close Price
$1.41
Day Range
$1.401.47
52-Week Range
$1.006.93
Bid/Ask
$1.49 / $1.98
Market Cap
$9.61 Mil
Volume/Avg
53,296 / 28,102

Key Statistics

Price/Earnings (Normalized)
Price/Sales
0.35
Dividend Yield (Trailing)
0.00%
Dividend Yield (Forward)
0.00%
Total Yield

Company Profile

Molecular Templates Inc is a clinical-stage biopharmaceutical company focused on developing therapeutic agents that selectively target tumor cells for the treatment of individuals living with cancer. Its pipeline products are MT-6402, MT-8421 and MT-0169.
Sector
Healthcare
Industry
Biotechnology
Stock Style Box
Small Value
Total Number of Employees
62

Competitors

Valuation

Metric
MTEM
LLY
RHHBY
Price/Earnings (Normalized)
79.4913.44
Price/Book Value
1.3558.907.48
Price/Sales
0.3520.603.55
Price/Cash Flow
79.8712.98
Price/Earnings
MTEM
LLY
RHHBY

Financial Strength

Metric
MTEM
LLY
RHHBY
Quick Ratio
1.360.610.80
Current Ratio
1.561.111.26
Interest Coverage
−116.0115.0811.62
Quick Ratio
MTEM
LLY
RHHBY

Profitability

Metric
MTEM
LLY
RHHBY
Return on Assets (Normalized)
−41.30%13.15%16.64%
Return on Equity (Normalized)
−455.09%69.16%53.11%
Return on Invested Capital (Normalized)
−101.32%23.97%25.43%
Return on Assets
MTEM
LLY
RHHBY

Biotechnology Industry Comparables

1-Day Chart
Name
Price
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
Novo Nordisk AS ADR
NVO
QbpdfxtsxVrff$512.4 Bil
Vertex Pharmaceuticals Inc
VRTX
TgzywbfvXzrcws$117.5 Bil
Regeneron Pharmaceuticals Inc
REGN
XfhpwfzcQpvpdm$111.6 Bil
Alnylam Pharmaceuticals Inc
ALNY
SsncpgxlMbfnrv$34.4 Bil
argenx SE ADR
ARGX
DjjdcqlHjlz$31.7 Bil
BioNTech SE ADR
BNTX
ThzsftxcqMkjd$29.2 Bil
Moderna Inc
MRNA
CnwszbjgGdzl$23.1 Bil
United Therapeutics Corp
UTHR
XvtykylxwKytgg$15.8 Bil
Biomarin Pharmaceutical Inc
BMRN
YnwzsptpFjjck$13.2 Bil
Incyte Corp
INCY
CwwymywPxjlbl$13.0 Bil

Sponsor Center